iciHaiti - NOTICE : A counterfeit medicine is circulating in Haiti

Haiti - News : Zapping...

Haiti - Politic : 2nd Meeting of the OAS Group of Friends of Haiti, Statement by the United States

Haiti - Security : The hellish life of Haitian children

Haiti - Politic : The OAS is holding more meetings on the roadmap

Haiti - FLASH : USA proposes a more aggressive repression force against gangs with more than 5,000 men

more news

iciHaiti - Nippes: The Government mobilizes significant resources to strengthen the health system

iciHaiti - FLASH : Mexico Excellence Scholarships, Registration Open

iciHaiti - Health : Medical equipment and vehicles delivered to the North and Center Departments

iciHaiti - Sports : Towards the 2025 Inter-University Championship

iciHaiti - Diaspora : Criminal record extract, towards faster service

more news

iciHaiti - NOTICE : A counterfeit medicine is circulating in Haiti
25/02/2024 09:04:19

The Ministry of Public Health and Population (MSPP) advises the general population and health professionals in particular that a counterfeit medicine sold under the name "FADA Fenobarbital" is circulating in Haiti.

This counterfeit product targeted by this alert, labeled "Fenobarbital sodico, IM/IV, 200mg/2ml" is presented in a transparent vial, covered with a double white label with letters printed in red. In reference to the primary packaging written in Spanish.

The Ministry specifies that:

- The name of the laboratory "NFADA PHARMA" is not registered in Haiti;

- The batch number (1372) and expiration date (12/2025) indicated on the label have no traceability in Haiti.

The use of falsified "Fenobarbital sodico, IM/IV, 200mg/2ml" may result in erroneous and ineffective treatment as well as other serious health risks due to the conditions of use which may, in certain circumstances, lead to life in danger.

The Ministry invites users to obtain their supplies exclusively from authorized pharmaceutical establishments (list on the MSPP website) and calls on the Population to be vigilant.

The purchase, distribution, sale and use of this counterfeit medicine meeting the characteristics mentioned is strictly prohibited on the national territory.

The Ministry urges health professionals and consumers in general to report any incident relating to pharmacovigilance to the Health Directorate of their respective jurisdiction for any appropriate immediate administrative action.

See also :
https://www.icihaiti.com/en/news-41737-icihaiti-health-alert-counterfeit-drug.html

IH/ iciHaiti